TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $181,000 | -36.7% | 377,925 | +77.0% | 0.00% | – |
| Q1 2019 | $286,000 | +77.6% | 213,536 | +49.6% | 0.00% | – |
| Q4 2018 | $161,000 | -56.6% | 142,775 | +6.4% | 0.00% | – |
| Q3 2018 | $371,000 | +498.4% | 134,208 | +676.0% | 0.00% | – |
| Q2 2018 | $62,000 | +72.2% | 17,295 | +47.8% | 0.00% | – |
| Q1 2018 | $36,000 | -70.5% | 11,700 | -39.9% | 0.00% | – |
| Q4 2017 | $122,000 | +149.0% | 19,480 | +172.1% | 0.00% | – |
| Q3 2017 | $49,000 | +40.0% | 7,159 | +43.4% | 0.00% | – |
| Q2 2017 | $35,000 | -67.3% | 4,991 | -57.2% | 0.00% | – |
| Q1 2017 | $107,000 | +122.9% | 11,665 | -2.5% | 0.00% | – |
| Q4 2016 | $48,000 | +60.0% | 11,968 | +54.5% | 0.00% | – |
| Q3 2016 | $30,000 | -44.4% | 7,747 | -37.6% | 0.00% | – |
| Q2 2016 | $54,000 | +80.0% | 12,406 | +87.7% | 0.00% | – |
| Q1 2016 | $30,000 | -86.0% | 6,609 | -69.1% | 0.00% | – |
| Q4 2015 | $214,000 | -84.2% | 21,355 | -88.3% | 0.00% | – |
| Q3 2015 | $1,357,000 | +451.6% | 181,926 | +3419.6% | 0.00% | – |
| Q2 2015 | $246,000 | +1540.0% | 5,169 | +1163.8% | 0.00% | – |
| Q1 2015 | $15,000 | -98.2% | 409 | -98.0% | 0.00% | – |
| Q4 2014 | $811,000 | +79.4% | 20,403 | -10.1% | 0.00% | – |
| Q3 2014 | $452,000 | +44.9% | 22,683 | -1.8% | 0.00% | – |
| Q2 2014 | $312,000 | -77.7% | 23,100 | -82.0% | 0.00% | -100.0% |
| Q1 2014 | $1,396,000 | +17350.0% | 128,295 | +23702.4% | 0.00% | – |
| Q4 2013 | $8,000 | 0.0% | 539 | -21.0% | 0.00% | – |
| Q3 2013 | $8,000 | -93.0% | 682 | -95.8% | 0.00% | – |
| Q2 2013 | $114,000 | – | 16,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |